Tumor metastasis correlated with worse prognosis, and COL4A1 expression in BC patients who received neoadjuvant chemotherapy could predict favourable OS and RFS as assessed via the Kaplan–Meier method (Figures 4(a) and 4(b)). The gene discussed is COL4A1; the disease is breast cancer.